Search Results - "Tzimopoulou, Sofia"

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy by Tziortzi, Andri C., Searle, Graham E., Tzimopoulou, Sofia, Salinas, Cristian, Beaver, John D., Jenkinson, Mark, Laruelle, Marc, Rabiner, Eugenii A., Gunn, Roger N.

“…[11C]-(+)-PHNO is a D3 preferring PET radioligand which has recently opened the possibility of imaging D3 receptors in the human brain in vivo. This imaging…”
Get full text

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease by Tzimopoulou, Sofia, Cunningham, Vincent J, Nichols, Thomas E, Searle, Graham, Bird, Nick P, Mistry, Prafull, Dixon, Ian J, Hallett, William A, Whitcher, Brandon, Brown, Andrew P, Zvartau-Hind, Marina, Lotay, Narinder, Lai, Robert Y K, Castiglia, Mary, Jeter, Barbara, Matthews, Julian C, Chen, Kewei, Bandy, Dan, Reiman, Eric M, Gold, Michael, Rabiner, Eugenii A, Matthews, Paul M

“…Here we report the first multi-center clinical trial in Alzheimer's disease (AD) using fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) measures…”
Get more information

Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A 18F-FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau-Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau-Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

P1‐112: Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A 18 F‐FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau‐Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

P1‐112: Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A 18F‐FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau‐Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

IC‐P‐088: Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F‐FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau‐Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

IC‐P‐088: Effects of 12 months of treatment with the PPAR γ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18 F‐FDG PET study by Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau‐Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.

Get full text

Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A18 F-FDG PET study by Rabiner, Eugenii A, Tzimopoulou, Sofia, Cunningham, Vincent J, Jeter, Barbara, Zvartau-Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P, Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E, Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M

Get full text

Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A18 F-FDG PET study by Rabiner, Eugenii A, Tzimopoulou, Sofia, Cunningham, Vincent J, Jeter, Barbara, Zvartau-Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P, Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E, Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M

Get full text

The virtuality of the digital by Sofia, T

“…This paper addresses the principal issues presented in the author's doctoral dissertation, at the School of Architecture at the Aristotle University of…”
Get full text